MOB — Moberg Pharma AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK434.29m
- SEK213.93m
- SEK13.54m
Brief: Moberg Pharma Receives Patent Granted For Mob-015 In China
Swedish stocks: Seen opening higher, Barclays ups target prices for Swedish banks
Brief: Moberg Pharma Q3 EBITDA At SEK 22.7 Mln
Brief: Moberg Pharma Signs Exclusive Agreement For Emtrix In Middle East And Africa
Brief: Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To Mob-015 From Moberg Pharma
Brief: Moberg Pharma And Cipher Pharmaceuticals Sign Exclusive License Agreement For Mob-015 In Canada
Brief: Moberg Pharma Q2 EBITDA Sek 25.4 Million
Swedish stocks: Seen opening lower, iZettle to list this year
Brief: Moberg Pharma Q1 EBIT Above Expectations At SEK 12.5 Million
Swedish stocks: Seen opening higher, Berenberg lifts view on Assa Abloy
Brief: Moberg Pharma: U.S. Patent Granted For BUPI
Swedish stocks: Seen opening higher in line with major European markets
Brief: Moberg Pharma Divests Balmex For $4.25 Million
Brief: Moberg Pharma Q4 EBITDA Above Expectations At SEK 27.0 Million
Brief: Moberg Pharma Receives Favorable Outcome From NAD
Brief: Moberg Pharma Reorganizes Its Commercial Operations
Brief: Moberg Pharma Q3 EBITDA up at SEK 36.0 mln
Brief: Moberg Pharma updates on timeline for MOB-015
Brief: Moberg Pharma patent granted in Canada